Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.
Zheng Q; Tang J; Aicher A; Bou Kheir T; Sabanovic B; Ananthanarayanan P; Reina C; Chen M; Gu JM; He B; Alcala S; Behrens D; Lawlo RT; Scarpa A; Hidalgo M; Sainz B; Sancho P; Heeschen C.
J Exp Clin Cancer Res
(Unknown)
Published: 2023
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes …
Castaldo V; Minopoli M; Di Modugno F; Sacconi A; Liguoro D; Frigerio R; Ortolano A; Di Martile M; Gesualdi L; Madonna G; Capone M; Cirombella R; Catizone A; Del Bufalo D; Vecchione A; Carriero MV; Ascierto PA; Mancini R; Fattore L; Ciliberto G.
J Exp Clin Cancer Res
(Unknown)
Published: 2023
TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting…
Huang J; Pan H; Sun J; Wu J; Xuan Q; Wang J; Ke S; Lu S; Li Z; Feng Z; Hua Y; Yu Q; Yin B; Qian B; Zhou M; Xu Y; Bai M; Zhang Y; Wu Y; Ma Y; Jiang H; Dai W.
J Exp Clin Cancer Res
(Unknown)
Published: 2023
Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer.
Cartry J; Bedja S; Boilève A; Mathieu JRR; Gontran E; Annereau M; Job B; Mouawia A; Mathias P; De Baère T; Italiano A; Besse B; Sourrouille I; Gelli M; Bani MA; Dartigues P; Hollebecque A; Smolenschi C; Ducreux M; Malka D; Jaulin F.
J Exp Clin Cancer Res
(Unknown)
Published: 2023
Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential.
Alors-Pérez E; Pedraza-Arevalo S; Blázquez-Encinas R; Moreno-Montilla MT; García-Vioque V; Berbel I; Luque RM; Sainz B; Ibáñez-Costa A; Castaño JP.
J Exp Clin Cancer Res
(Unknown)
Published: 2023
Antibody drug conjugates: hitting the mark in pancreatic cancer?
J Exp Clin Cancer Res
(Unknown)
Published: 2023
Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT).
Genta S; Lajkosz K; Yee NR; Spiliopoulou P; Heirali A; Hansen AR; Siu LL; Saibil S; Stayner LA; Yanekina M; Sauder MB; Keshavarzi S; Salawu A; Vornicova O; Butler MO; Bedard PL; Razak ARA; Rottapel R; Chruscinski A; Coburn B; Spreafico A.
J Exp Clin Cancer Res
(Unknown)
Published: 2023
ERRα promotes glycolytic metabolism and targets the NLRP3/caspase-1/GSDMD pathway to regulate pyroptosis in endometrial…
Su P; Mao X; Ma J; Huang L; Yu L; Tang S; Zhuang M; Lu Z; Osafo KS; Ren Y; Wang X; Lin X; Huang L; Huang X; Braicu EI; Sehouli J; Sun P.
J Exp Clin Cancer Res
(Unknown)
Published: 2023